Side-by-side comparison of AI visibility scores, market position, and capabilities
Personalized vitamin subscription brand acquired by Bayer for $225M in 2020; continues as digital-native supplement label under Bayer Consumer Health.
Care/of is a New York-based personalized vitamin and supplement brand founded in 2016 by Craig Elbert and Akash Shah. The company popularized algorithm-driven supplement personalization, asking consumers a series of lifestyle and health questions to recommend a custom daily vitamin pack delivered by subscription. Care/of was acquired by Bayer in November 2020 at a $225 million valuation, giving Bayer a majority ownership stake in the direct-to-consumer brand.\n\nUnder Bayer's Consumer Health division, Care/of has continued to operate with its original DTC model and brand identity while leveraging Bayer's supply chain, clinical validation resources, and marketing infrastructure. The brand extended its product line to include protein powders, collagen supplements, and wellness shots, maintaining its personalization-first positioning in a crowded supplement market.\n\nCare/of targets millennial consumers who value personalized wellness plans and want evidence-cited ingredient explanations. The brand's website provides research citations for every recommended ingredient, a transparency approach that built early credibility and loyalty. As part of Bayer, Care/of benefits from credentialing by association with a global pharmaceutical brand while retaining its digital-native identity.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.